Russell W Chan

Russell W Chan

Engineer, Scientist and Entrepreneur in Biomedical Imaging (HKU, Stanford, NYU)

E-SENSE Innovation & Technology

Biography

I am Dr. Russell Chan, co-founder and CEO of E-SENSE Innovation & Technology. I hold a B.Eng. in Biomedical Engineering and a Ph.D. in Electrical and Electronic Engineering from HKU, with postdoctoral experience at Stanford and NYU in neurology, neuroscience, and ophthalmology. Previously, I co-founded a Forbes Asia 100 to Watch startup and was named REVIVE CTO of the Year in 2023. Under my leadership, E-SENSE received Tech Impact Company of the Year at Tech Fest Hong Kong 2025 and a Gold Medal with Jury Congratulations at the 50th International Exhibition of Inventions of Geneva. My focus is advancing multi-modal biomedical imaging technologies to improve quality of life. I’m a Junior Fellow of ISMRM, Young Fellow of HKAE, and former R&D lead of the HKIE Biomedical Division.

Interests
  • Biomedical Imaging (EIT, MRI, and Optoacustic)
  • Brainwide networks, and Neurodegenerative Diseases
  • Neuromodulation tools
Education
  • B.Eng. in Biomedical Engineering, 2011

    The University of Hong Kong

  • Ph.D. in Biomedical Imaging, 2016

    The University of Hong Kong

  • Postdoc in Neurology and Neurological Sciences, 2020

    Stanford University

  • Postdoc in Tech4Health, Neuroscience, Ophthalmology, 2021

    New York University

Experience

 
 
 
 
 
Co-founder and CEO
September 2023 – Present Hong Kong
Leading 10+ PhDs, engineers, research associates, sales and staff in fund raising, R&D, engineering, commercialization, clinical trials, and sales of the next generation point-of-care vital organ biomedical imaging device (medical grade). Steering E-SENSE to revolutionize emergent and chronic organ disease management by enabling rapid healthcare services alongside emergent and chronic disease screening, monitoring, and prevention — supporting all vital organs including the brain, heart, lungs, liver, and kidneys.
 
 
 
 
 
CEO
September 2023 – August 2024 Hong Kong
Leading 30+ researchers, engineers, technicians, and staff in R&D, engineering, commercialization, and clinical trials of the next generation BioRadar® system – a point-of-care in vitro diagnostic (IVD) device. Steering HKLife to revolutionize the practice of clinical diagnostics, providing effective platforms for point-of-care applications focused on personalized medicine and pre-emptive surveillance of emerging pathogens and diseases;
 
 
 
 
 
Co-founder and CTO
January 2022 – August 2023 Hong Kong
Leading 10+ PhDs, engineers, and research associates in R&D of a portable cloud-based biomedical imaging device (non-medical grade). Oversea research, development, application, and commercialization of portable biomedical imaging and spectroscopy systems (electrical impedance tomography and spectroscopy technologies) for health referencing (including lung, liver, and kidney diseases).
 
 
 
 
 
Postdoc
December 2020 – November 2021 New York, USA
Design and implement neuroimaging and neuromodulation methods including optoacoustic imaging, magnetic resonance imaging, transcranial focused ultrasound, and optogenetic tools Investigate brain networks in humans, rodent models, glaucoma patients and rodent glaucoma models Study cerebral spinal fluid (CSF) flow in rodent models and rodent Alzheimer’s disease models
 
 
 
 
 
Postdoc
October 2017 – August 2020 Palo Alto, USA
Designed and implemented layer-specific optogenetic fMRI and electrophysiological recording methods Discovered distinct brain functional networks related to motion, Parkinson’s disease, Alzheimer’s disease and epilepsy using novel neuromodulation and neuroimaging approaches Established mesoscale layer-specific fMRI representation of neural activityDesign and implement neuroimaging and neuromodulation methods including optoacoustic imaging, magnetic resonance imaging, transcranial focused ultrasound, and optogenetic tools
 
 
 
 
 
PhD & Postdoc
September 2011 – October 2017 Hong Kong
Led the design and implementation of novel neuroimaging procedures namely optogenetic fMRI, resulting in four first author journal papers and media coverage Discovered hippocampus being a key brain functional connectivity hub related to learning and memory, and provided insights to Alzheimer’s disease Demonstrated low frequency activities of excitatory neurons contribute to resting-state fMRI networks

Recent Publications

Quickly discover relevant content by filtering publications.

Projects

.js-id-e-sense
Co-founder of E-SENSE
Revolutionizing Emergent and Chronic Organ Disease Management for Millions with E-SENSE.
Co-founder of E-SENSE

Contact

In case this doesn’t work, email me instead.